ACN — long thesis
Thesis
ACN Q2 FY2026 BEAT CONFIRMED — EPS $2.93 beat $2.87 estimate, revenue $18.04B beat $18.01B estimate. Record bookings of $22.1B for the quarter. Revenue growth 8.3% YoY. Stock surged 4.4% to $203 on the beat. However, Q3 revenue guidance slightly below consensus and full-year EPS guidance merely in-line. Stock is down 21% YTD at ~$203, trading at ~16x trailing P/E. Average analyst PT of $283.50 implies ~40% upside. The AI consulting thesis is being validated — AI bookings nearly doubled YoY. Enterprise AI spending is accelerating through consulting implementers like ACN regardless of which vendor wins. At $203 post-beat, ACN is within the original entry zone of $190-205. The earnings beat de-risks near-term and confirms AI consulting demand strength.
Triggers
Entry: ACN at $203 post-earnings beat. Stock is within the original $190-205 entry zone. If stock consolidates above $200 for 1-2 sessions, buy $40-50 worth. The Q2 beat and record $22.1B bookings provide fundamental validation. Entry zone: $195-210 on post-earnings stabilization.
Exit: Target 15-20% upside from entry over 3-6 months as enterprise AI consulting demand accelerates. Take partial profits at $230. Stop loss at 15% below entry.
Invalidation: Enterprise AI spending decelerates materially. Major consulting deal cancellations. ACN-specific execution issues or margin compression. Stock drops more than 20% from entry. AI tools automate consulting work faster than expected, reducing demand for human services.